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Epidemiology of stroke
Abstract
The epidemiology of stroke may be changing over time as a result of a
number of factors, including an aging population and advances in the pre-
vention and treatment of stroke. Epidemiological indicators and research of
stroke have great significance in estimating the impact of this disease on the
population. Such research states the distribution of this illness and factors by
which it is influenced, follows short-term and long-term consequences, as
well as socio-economic burden of stroke for the whole community.
Data on stroke prevalence is important for creating the right strategies for
health care in a specific area. Stroke-related mortality in any population is de-
pendent upon three main factors: the incidence of stroke in the population,
quality of medical care available, and the prevalence of cardiovascular disea-
ses and comorbidities that can affect the likelihood of surviving stroke events.
The quality of medical care available influences both the number of indivi-
duals suffering from stroke and the proportion of case-fatality among them.
Epidemiological data shows that stroke is one of the leading causes of
death and long-term disability in most industrialized populations, and the
same is true for Croatia. The existing system of health care for stroke patients
does not meet the needs and is not in accordance with latest trends in
developed countries. Hence, there is a need for its reorganization and design
of the national project for stroke prevention and treatment similar to those
in European countries with favorable epidemiological data.
INTRODUCTION
Stroke is one of the largest health burdens in most industrialized po-pulations, as well as in Croatia. The epidemiology of stroke may be
changing over time as a result of a number of factors, including an ag-
ing population and advances in the prevention and treatment of stroke.
Given the observed changes in the epidemiology of stroke over time, it
is important to obtain a good overview of the most recent data. Epide-
miological indicators and results of neuroepidemiological research of
stroke and other cerebrovascular diseases have great significance in esti-
mating the scope of the problem of stroke in the population. Such re-
search states the distribution of this illness and factors by which it is in-
fluenced, follows short-term and long-term consequences, as well as
socio-economic burden of stroke for the whole community. Epidemio-
logical trials usually include hospital material, but population trials
provide the most accurate epidemiological data. Whereas population
trials are important for stating morbidity (incidence and prevalence),
mortality, long-term outcome and life quality after stroke, clinical epi-
demiological trials enable estimation of case fatality and short-term
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Overview
Neuroepidemiological research encounters many me-
thodological problems. Population research depends on
specific knowledge and willingness of participants in the
research. Although the most reliable data include deceas-
ed who died in hospitals, not even they are completely
accurate, unless they are confirmed by an autopsy. Test
results of a coroner are even less accurate. Some cases of
stroke do not have to manifest themselves in classic signs,
such as motor paralysis and speech problems, which
causes difficulties in diagnosis. It is hard to make a diag-
nosis on people who died suddenly outside the hospital,
due to more difficult differentiation of cardiovascular,
cerebrovascular and other causes of death. Apoplectic
syndrome can be caused by other factors, such as decom-
pensated brain tumors or other acute disorders of the
central nervous system (1).
Modern research of neurological diseases in Croatia
started at the end of 1960’s and in the early 1970’s. Pursu-
ant to the instructions of World Health Organization
(WHO), a group of experts performed systematic epide-
miological research in the Centre for Cerebrovascular
Diseases »Trnje« in Zagreb. The first symposium on ce-
rebrovascular diseases was held in Zagreb in 1971. On
the second symposium, which was held in 1974 with par-
ticipation of experts from WHO, one of the main topics
was epidemiology of cerebrovascular diseases (CVD).
Methodologies of many specific subjects, important for
diagnostics and therapy of these diseases, had epidemio-
logical characteristics. In that way modern concept of
treating CVD started to form: prevention, early diagnosis
and urgent treatment, as well as directed neuroepide-
miological research of problems in this area (2).
DEFINITION AND CLASSIFICATION
WHO defines stroke as »rapid development of clinical
signs of focal (or global) brain function disorders, with
symptoms which last 24 hours or longer or lead to death,
without other clear cause, except signs of blood vessel
damage« (3). This disease is classified into two main
types: brain ischemia due to thrombosis, embolism or
systemic hypoperfusion and brain hemorrhage due to
intracerebral or subarachnoidal hemorrhage. 80 % of
strokes are caused by ischemia and the rest by hemorrhage.
Two main categories of this disease are diametrically op-
posite: hemorrhage is characterized by an excessive amount
of blood inside the closed intracranial cavity, whereas
ischemia is characterized by lack of blood and inade-
quate amount of oxygen and nutrients in a specific part
of brain. Each of these categories can be divided into
subtypes, which have different causes, clinical manifesta-
tions, clinical course, outcome and therapeutic strategies.
There are different approaches to classification of acute
stroke. International classification of diseases and pro-
blems made by the WHO regarding health (tenth audit-
-ICD 10) includes diseases and signs, symptoms, abnor-
mal test results, complaints, social circumstances and
external causes of injuries and illnesses. This classifica-
tion classifies stroke under codes from I 60 to I 69 into
following subgroups: subarachnoidal hemorrhage, intra-
cerebral hemorrhage, other non-traumatic hemorrhages,
cerebral infarct caused by extracerebral or intracerebral
occlusion, as well as non-specific stroke (4).
Classification of Oxford Community Stroke project is
primarily based on initial symptoms; episodes of stroke
are classified based on development of symptoms such
as: primary intracerebral hemorrhage, total anterior cir-
culation syndrome, partial anterior circulation syndro-
me, lacunar circulation syndrome and posterior circula-
tion syndrome. These five entities anticipate the develop-
ment of stroke, part of brain which was compromised,
the main cause behind the incident and disease prog-
nosis (5, 6). TOAST (Trial of Org 10172 in Acute Stroke
Treatment) classification of ischemic stroke is very practical
and is based on clinical symptoms, as well as on results of
further research. Based on that, stroke is classified as a
consequence of: thrombosis or embolism due to athero-
sclerosis of large blood vessels; embolism which started
in the heart; occlusion of small blood vessels; other stated
causes; undetermined causes (two possible causes, one
unidentified cause or incomplete research) (7).
Classical definition of transitory ischemic attack (TIA)
is a sudden start of focal neurological symptom and/or
sign, which lasts less than 24 hours and probably is
caused by temporary reduced bloodstream, which leads
to brain ischemia in the area, which produces symptoms.
Recovery period of blood stream is enough to make
ischemia temporary and to avoid infarction. Neverthe-
less, arbitrary nature of 24-hour time limit and lack of
specific pathophysiological significance reduces clinical
and research usefulness of the TIA term. Recognition of
these terms led to evolution in a definition and that
process was supported by improvements in neuroimag-
ing, especially by imaging measured by diffusion, which
enables very early identification of ischemic brain damage.
Infarction usually develops when focal temporary neuro-
logical symptoms last more than one hour. So the benign
connotation of the term »TIA« is changed by cognition
that even small ischemia can cause permanent brain
damage. Based on facts stated in the past years, redefin-
ing of criteria is suggested, according to which TIA would
include neurological symptoms, which last less than an
hour without image evidence on ischemia of brain tissue,
and ischemic stroke includes neurological symptoms,
which last more than an hour and/or when there are
imaging evidence of brain tissue damage (8).
NEUROEPIDEMIOLOGICAL DATA
Incidence
Well performed trials on stroke incidence include us-
age of standard definition, which was provided by WHO,
prospective studies on a large, well defined and represen-
tative sample, as well as comprehensive and understand-
able methodology of detecting the ill and identifying
non-fatal cases treated outside the hospital and those
who died soon after the illness started. Stroke incidence,
strictly speaking, would refer to incidents which appear
254 Period biol, Vol 114, No 3, 2012.
D. Kadoji} et al. Epidemiology of stroke
for the first time in life of a person (first-ever stroke), but
some trials include also recurrent strokes. It is estimated
that approximately 4 million people suffer from stroke
annually. Out of that number, approximately 570 000 cases
occur in Europe and approximately 500 000 in United
States of America. Age-standardised incidence rates are
usually used in stroke incidence reviews. International
epidemiological trials show that rates grow exponentially
with age, from 0.3‰ in the third and fourth decade of
life, all the way to 30‰ in the eighth and ninth decade of
life, which makes an average of 1–2‰. Recent data shows
that the incidence of stroke in France is 114 cases per
100 000 persons per year, in Germany 350, in Italy 223, in
Spain 141–220, and in UK 161 (9). In 2005 a multicentric
trial of incidence of stroke and transitory ischemic at-
tacks was implemented with the aim of determining real
incidence rates of acute cerebrovascular diseases in Repub-
lic of Croatia (RC). The research used internationally
accepted methodology and was performed during one
year period from January 1st till December 31st, 2005. All
cases of stroke and TIA were carefully recorded in coope-
ration with primary care physicians. Multicentric trial
included population of 89 501 people of all age in four
macroregional centres of RC (Osijek-Slavonski Brod,
Split, Rijeka and Zagreb). Stroke incidence rate for the
entire area of RC amounted to 251/100 000. In individual
regional centres the following stroke incidence rates were
noted: Osijek-Slavonski Brod 302/100 000, Zagreb 290/100
000, Rijeka 220/100 000, Split 196/100 000. TIA incidence
rate for the entire area of RC amounted to 101/100 000. In
individual regional centres the following TIA incidence
rates were noted: Osijek-Slavonski Brod 157/100 000,
Zagreb 87/100 000, Rijeka 90/100 000, Split 22/100 000.
In the continental part of the RC (Osijek-Slavonski Brod,
Zagreb) Stroke incidence rate amounted to 298/100 000,
and TIA incidence rate amounted to 130/100 000. In the
coastal part of the RC (Split, Rijeka) stroke incidence rate
amounted to 205/100 000, and TIA incidence rate
amounted to 49/100 000. Stroke incidence was 1.45 times
bigger, and TIA incidence was 2.64 times bigger in the
continental part than in the coastal part of the RC. The
trial revealed relatively high incidence rates of acute CVD
(stroke and TIA) in the RC, which confirmed that CVDs
are a large public health problem. Significantly higher
incidence rates in the continental part of the country
than in the coastal area showed that way of life and
environment influence development of stroke and other
cerebrovascular disorders (10).
Prevalence
Data on stroke prevalence is the best indicator of how
spread a disease is in a population and it also enables
creating right strategies of health actions and total health
care in a specific area. Stroke prevalence rates in the
world vary between 5‰ and several percentages. Recent
data show that the prevalence of stroke in Italy is 1.47%,
in UK 1.7% and in US 2.6% (9). Several years ago the
population epidemiological trial was implemented in
our country with the aim of determining prevalence of
acute CVD: TIA and stroke in the Osijek-Baranya Co-
unty. Internationally acknowledged work methodology
for the population epidemiological trials, which was re-
commended by the WHO was used in this research.
So-called door-to-door epidemiological research was im-
plemented with a help of a questionnaire, which was
designed by neurological experts experienced in stroke
problems, and afterwards additional data control was
performed in medical charts of people included in the
trial, in cooperation with doctors of primary health care.
The trial included population of 1423 people of all age.
Prevalence of acute CVD was 3.30%, out of which 2.04%
was stroke prevalence and 1.26% was TIA prevalence. In
men, CVD prevalence amounted to 3.04%, out of which
1.88% was stroke and 1.16% was TIA. In women, CVD
prevalence of 3.56% was recorded, out of which 2.19%
was stroke and 1.37% was TIA. Prevalence of acute CVD
is increasing progressively as the population gets older. In
the age group 55–64 it amounted to 9.44% (stroke 6.67%
and TIA 2.78%), in the age group 65–74 it amounted to
10.60% (stroke 6.82% and TIA 3.79%), and the highest
prevalence was recorded in the age group 75–84 where it
amounted to 14.86% (stroke 10.81% and TIA 4.05%).
The trial has shown high prevalence rate of acute CVD
in the Osijek-Baranya area and has confirmed that these
diseases are one of the leading public health problems in
Eastern Croatia (11).
Mortality
Mortality related to stroke in any population is de-
pendent upon three main factors: the incidence of stroke
in the population, the quality of medical care available to
individuals who have suffered a stroke and the preva-
lence of cardiovascular disease and comorbidities that
can affect the likelihood of patients surviving stroke eve-
nts. The quality of medical care available influences both
the number of individuals suffering from stroke and the
proportion of case-fatality among them. Worldwide, the-
re are approximately 4.6 million deaths from stroke each
year, and three quarters of these occur in developing
countries. The estimate is based on death certificate data,
which cover only about one third of the world’s popula-
tion, and extrapolation from total mortality rates. Despite
their limitations, death certificate data show that in recent
decades stroke death rates have declined dramatically, at
least in industrial countries, with as much as a 7% per
annum decline occurring in Japan since the mid-1970s
(12). In developing countries where death certificate in-
formation is available, the general trend is also downward.
Not all countries have benefited, however. Countries in
Eastern European region still register high stroke death
rates. Mortality rates for stroke in Europe vary signifi-
cantly. The highest rate of 249/100 000 was noted in
Bulgaria, and the lowest of 27/100 000 in Switzerland.
Recent data show that the age-standardised stroke-mor-
tality rates in France are 24–38, in Germany 37–47, in
Italy 41–68, in Spain 38–52, in UK 46–53 and in US
32–35 deaths per 100 000 persons per year (9). East
European countries have higher total mortality, whereas
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the lowest rates were noted in Scandinavian countries,
Switzerland and the Netherlands. Mortality rates were
dramatically reduced in the past few decades in Japan
and West European countries. In comparison, in East
European countries there has been a constant increase in
mortality rate caused by stroke in the same period, which
continued in transition period of these countries.
Trials that show secular changes in mortality caused
by some diseases, throughout a long period of years or
decades, have a special significance. To analyse secondary
trend of dying age, periodical and generation impacts
should be taken into consideration. Secular trend of dy-
ing from stroke in the USA in the period 1900–1995 is
shown by the following mortality rates per 100 000 inha-
bitants. The rate was 106.3 in 1900, 104 in 1950, followed
by a decrease to 74.6 in 1980 and to 57.9 in 1990. After
that, the trend of decreasing mortality rate stopped, and
in 1995 the rate of 60.2 was noted. A significant trial on
secular trends of dying from stroke in Croatia was con-
ducted in the period of 30 years, from 1958 to 1997, and
showed a constant trend of mortality increase from this
disease during that period. Whereas total number of
inhabitants increased by 14% during the observation
period, number of deceased from stroke increased by
64%. Proportional mortality rate from CVD, for popula-
tion 35–74 years of age, increased from 9% in 1958 to
14,9% in 1987, and standardized mortality rate from
stroke for population 35–74 years of age increased from
118/100 000 to 191/100 000 inhabitants. Data analysis for
the next ten years showed that secular trend of growth of
total number of deceased and growth of proportional
mortality rate from CVD had continued in a population
35–74 years of age. Mortality rates are especially high in
the continental area, in cities Osijek and Vara`din, and
they are, in some cases, 2–3 times higher than in coastal
area (13). If we compare age standardized mortality rates
in Croatia and in Europe from the database of the WHO
program »Health for Everybody«, the rate for cerebrovas-
cular diseases for all ages in total amounted to 127.8 in
2004 for Croatia, and to 57.1 for the EU members before
2004 (2003 was the last available year), and 107.0/100 000
for the EU members since 2004. For age group 0–64, the
rate in Croatia was 20.9, slightly lower than rate in »new«
EU members (21.1), but almost 3 times higher than
mortality rate in »old« EU members 7.6/100 000. (14).
The latest data showed that out of all deceased in Croatia
in 2008, 9.6 percent died from stroke and its consequen-
ces, which was 6190 people. Mortality rate for stroke in
2008 was 182.0/100 000 (15).
Case fatality
Case fatality is a proportion of patients who suffered
from stroke, and who died after a specific period after the
illness occurred. It is usually expressed as a percentage of
deceased in the 28-day period. Predicators that influence
early mortality are: localisation and size of infarct and
haemorrhage, degree of consciousness disorders, degree of
neurological deficit, older age, male gender, diabetes, arte-
rial hypertension, cardiac diseases, temperature, dyspha-
gia, sphincter incontinence, etc. Fatal outcome of stroke
is caused by central and peripheral complications. The
most frequent central complications are: cerebral oedema,
transtentorial herniation, hemorrhagic transformation of
ischemia, epileptic seizures, depression. More frequently,
the death of patients with stroke is caused by peripheral
(systemic) complications: deep venous thrombosis and
pulmonary embolism, bronchopneumonia, urinary in-
fection, septicaemia, aspiration, cardiac arrhythmia, myo-
cytolysis, uncontrolled hypotension, sudden death. It is
estimated that approximately one third of people who
suffered from stroke die, one third has severe and one
third mild residual neurological deficit, or is without
deficit. Factors which point out to poor outcome of stroke
are: older age, male gender, presence of diabetes, arterial
hypertension and cardiac disease, temperature, dysphagia,
incontinence, loss of consciousness, severe neurological
deficit, cognitive disorders, localisation and infarct size,
oedema and moving of central structures, biochemical
and haematological disorders, etc. Our research of short-
-term and long-term outcome of ischemic stroke showed
that approximately one quarter of patients die in the first
month and approximately one half in the next six months.
Mortality in five-year period after ischemic stroke goes
up to 60%. Among patients approximately 75% of cases
are the first, and 25% of cases are recurrent strokes. Risk
of recurrent stroke is the highest in the first year and is
around 10 %, and every other year around 5 % (16). The
most important indicators for recurrent stroke are: type
of stroke, earlier TIAs, arterial hypertension, heart valve
disease, arterial fibrillation, congestive heart failure, high
level of glucose in blood, male gender and alcohol abuse.
CONCLUSION
Epidemiological data shows that stroke is one of the
leading causes of death and long-term disability in most
industrialized populations, as well as in our country.
Community-based studies are important for the assess-
ment of morbidity (incidence and prevalence), mortality
and long-term outcome of stroke. Hospital-based studies
enable the assessment of case fatality and short-term
outcome of stroke. In epidemiological researche of stroke
it is necessary to use internationally accepted standards.
Although results on stroke epidemiology in our country
are outdated and incomplete, studies conducted on hos-
pital material in the last two decades show the current
state and point to negative trends in stroke incidence,
prevalence and case fatality. The existing system of health
care for stroke patients does not meet the needs and is not
in accordance with latest trends in developed countries.
Hence, there is a need for the reorganization of the
health care system and design of the national project for
stroke prevention and treatment similar to those in Euro-
pean countries with favourable epidemiological data.
Croatian Association for Neurovascular Disorders of
Croatian Medical Association and Croatian Association
for Stroke Prevention created guidelines for modern ap-
proach to treatment and stroke prevention (17). Also,
implementation of National Project of Taking Care of
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Patients with Stroke, which was created by the Ministry
of Health of the Republic of Croatia, is underway. The
final results of these activities should be reduced mor-
bidity, mortality and case-fatality from stroke, prevented
invalidity and incapability, improved life quality, as well
as reduced social and economic burden of this decease on
the whole community.
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